Veru Inc. (VERU) Financial Statements (2024 and earlier)

Company Profile

Business Address 2916 N. MIAMI AVENUE
MIAMI, FL 33127
State of Incorp. WI
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
ASSETS
Current Assets
Receivables13,6194,2063,8643,5518,30310,635
Inventory, net of allowances, customer advances and progress billings6,4907,6658,7338,6197,7236,415
Inventory6,4907,6658,7338,6197,7236,415
Other undisclosed current assets23,11231,41760,41292,600112,335123,411
Total current assets:43,22143,28873,009104,769128,361140,461
Noncurrent Assets
Operating lease, right-of-use asset4,4954,6764,6014,7874,9705,133
Property, plant and equipment1,4921,5201,4261,1861,0821,025
Long-term investments and receivables 4,438     
Accounts and financing receivable, after allowance for credit loss 4,438     
Intangible assets, net (including goodwill)6,9036,92110,83810,85610,87410,892
Goodwill6,8796,8796,8796,8796,8796,879
Intangible assets, net (excluding goodwill)24423,9603,9773,9954,013
Deferred income tax assets13,09813,07013,05212,96613,00613,019
Other noncurrent assets1,5487798561,5622,2852,294
Total noncurrent assets:31,97426,96530,77431,35732,21732,364
TOTAL ASSETS:75,19570,254103,782136,126160,577172,825
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18,11917,23710,56722,0036,9367,518
Accounts payable18,11917,23710,56722,0036,9367,518
Deferred compensation liability3,5462,9877,1365,9874,0172,387
Other liabilities2,7902,8117,0272,2502,1332,191
Other undisclosed current liabilities3,23116,22415,35011,19814,7239,085
Total current liabilities:27,68639,26040,08041,43827,80921,181
Noncurrent Liabilities
Long-term debt and lease obligation:    4,0944,2644,445
Liabilities, other than long-term debt3,8454,0214,0521007878
Deferred income tax liabilities   63816363
Other liabilities403326191515
Operating lease, liability3,8053,9883,9634,0944,2644,445
Other undisclosed noncurrent liabilities9,27710,25710,5519,65611,55711,121
Total noncurrent liabilities:13,12214,27814,60313,85015,90015,645
Total liabilities:40,80853,53854,68455,28743,71036,827
Equity
Equity, attributable to parent34,38716,71649,09980,839116,868135,998
Common stock914848828827823823
Treasury stock, value(7,807)(7,807)(7,807)(7,807)(7,807)(7,807)
Additional paid in capital276,756265,466259,075253,974248,984245,920
Accumulated other comprehensive loss(582)(582)(582)(582)(582)(582)
Accumulated deficit(234,895)(241,209)(202,416)(165,574)(124,552)(102,356)
Total equity:34,38716,71649,09980,839116,868135,998
TOTAL LIABILITIES AND EQUITY:75,19570,254103,782136,126160,577172,825

Income Statement (P&L) ($ in thousands)

9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
Revenues3,3416,5862,5082,5899,60213,028
Cost of revenue
(Cost of Goods and Services Sold)
(2,111)(2,494)(1,806)(2,083)(2,534)(1,853)
Gross profit:1,2314,0927025057,06911,175
Operating expenses(13,828)(43,511)(36,290)(45,178)(28,892)(22,940)
Other undisclosed operating income (loss)17,457     
Operating income (loss):4,859(39,419)(35,588)(44,673)(21,824)(11,765)
Nonoperating income (expense)1,512559(1,322)3,662(234)(2,440)
Investment income, nonoperating1,7891,200(670)4,114881(1,229)
Other nonoperating income (expense)37257221360701
Interest and debt expense(649)(698)(873)(812)(1,185)(1,213)
Income (loss) from continuing operations before equity method investments, income taxes:5,723(39,557)(37,784)(41,823)(23,243)(15,418)
Other undisclosed income from continuing operations before income taxes6496988738121,1851,213
Income (loss) from continuing operations before income taxes:6,372(38,859)(36,910)(41,011)(22,058)(14,205)
Income tax expense (benefit)(58)6768(12)(138)27
Income (loss) from continuing operations:6,314(38,793)(36,842)(41,023)(22,196)(14,178)
Loss before gain (loss) on sale of properties:(41,023)(22,196)(14,178)
Net income (loss) available to common stockholders, diluted:6,314(38,793)(36,842)(41,023)(22,196)(14,178)

Comprehensive Income ($ in thousands)

9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
Net income (loss):6,314(38,793)(36,842)(41,023)(22,196)(14,178)
Comprehensive income (loss), net of tax, attributable to parent:6,314(38,793)(36,842)(41,023)(22,196)(14,178)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: